C1A
C1A is a class I/II HDACs and sirtuin inhibitor with an IC50 of 479 nM for HDAC6. C1A induces sustained acetylation of HDAC6 substrates, α-tubulin and HSP90. C1A shows srtong anticancer effcts, and induces apoptosis in cancer cells.
For research use only. We do not sell to patients.
- CAS No.: 1021463-02-4
- Formula: C22H25Cl2N3O4S
- Molecular Weight:498.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
HDAC6 0.48 μM (IC50) |
HDAC8 0.61 μM (IC50) |
HDAC3 5.5 μM (IC50) |
HDAC10 9.8 μM (IC50) |
HDAC2 11 μM (IC50) |
HDAC1 14 μM (IC50) |
HDAC5 15 μM (IC50) |
HDAC4 16 μM (IC50) |
HDAC7 49 μM (IC50) |
HDAC9 56 μM (IC50) |
SIRT3 55 μM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| KMS-11 | GI50 |
0.48 μM
Compound: 22
|
Antiproliferative activity against human KMS-11 cells incubated for 72 hrs by sulphorhodamine B assay
Antiproliferative activity against human KMS-11 cells incubated for 72 hrs by sulphorhodamine B assay
|
[PMID: 29133060] |
| SH-SY5Y | IC50 |
0.28 μM
Compound: 22
|
Antiproliferative activity against human SH-SY5Y cells incubated for 72 hrs by sulphorhodamine B assay
Antiproliferative activity against human SH-SY5Y cells incubated for 72 hrs by sulphorhodamine B assay
|
[PMID: 29133060] |
In Vitro
C1A (2.5-10 μM; 24 h) increases the sub-G1 population in a drug concentration-related manner. And C1A induces apoptosis and inhibits proliferation of a panel of human tumour cell lines from different origins in the low micromolar range[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT-116 cells
-
Concentration:2.5 μM, 5 μM, 7.5 μM, 10 μM
-
Incubation Time:24 h
-
Result:Increased the sub-G1 population in a drug concentration-related manner.
-
Cell Line:HCT-116 cells
-
Concentration:0.5 μM, 1 μM, 2.5 μM, 5 μM, 7.5 μM, 10 μM
-
Incubation Time:4 h and 24 h
-
Result:Induced sustained acetylation of HDAC6 substrates, α-tubulin and HSP90.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female nu/nu-BALB/c mice injected with HCT-116 cells[1]
-
Dosage:20 mg/kg, 40 mg/kg
-
Administration:ip; once a day, twice a day, once every two days; for 14 days
-
Result:Inhibited the growth of colon tumours in vivo.
Chemical Information
-
CAS No. 1021463-02-4
-
Molecular Weight 498.42
-
Formula C22H25Cl2N3O4S
-
SMILES
ClCCN(C1=CC=C(C=C1)S(NC2=CC=C(C=C2)/C=C(C)/C=C/C(NO)=O)(=O)=O)CCCl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)